Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
58,837,653
-
Total 13F shares
-
36,751,259
-
Share change
-
+490,332
-
Total reported value
-
$384,781,646
-
Price per share
-
$10.47
-
Number of holders
-
74
-
Value change
-
+$4,830,426
-
Number of buys
-
30
-
Number of sells
-
33
Institutional Holders of Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM) as of Q1 2022
As of 31 Mar 2022,
Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,751,259 shares.
The largest 10 holders included
BIOIMPACT CAPITAL LLC, BVF INC/IL, CHI Advisors LLC, VANGUARD GROUP INC, BlackRock Inc., FMR LLC, BAUPOST GROUP LLC/MA, EVENTIDE ASSET MANAGEMENT, LLC, AMERICAN INTERNATIONAL GROUP, INC., and Nextech Invest AG.
This page lists
74
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.